[Are estrogens responsible for incidents observed under combined estrogen-progestagen treatment?].
Cohen
J
J
Bazin
C
C
Rozenbaum
J
J
D001695:Biology; D001769:Blood; D002241:Carbohydrates; D002319:Cardiovascular System; D002490:Central Nervous System; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D004194:Disease; D004617:Embolism; D005193:Family Planning Services; D005947:Glucose; D008055:Lipids; D008099:Liver; D008660:Metabolism; D010827:Physiology; D013923:Thromboembolism; D014652:Vascular Diseases
D002241:Carbohydrates; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D008055:Lipids; D005947:Glucose
Biology; Carbohydrate Metabolic Effects; Cardiovascular Effects; Central Nervous System; Central Nervous System Effects; Contraception; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin; Contraceptive Agents--side effects; Diseases; Embolism; Family Planning; Glucose Metabolism Effects; Hematological Effects; Hemic System; Hepatic Effects; Lipid Metabolic Effects; Lipids; Literature Review; Metabolic Effects; Oral Contraceptives; Physiology; Thromboembolism; Vascular Diseases